Elixinol (ASX: EXL) will finally be able to sell its CBD products in Australia after penning an exclusive distribution agreement with licenced wholesaler PharmaCann.
Under the agreement PharmaCann will import and supply Elixinol’s branded CBD products into Australia from the US, opening the company up to a brand new market.
“We regularly receive queries about whether our products are accessible in Australia, so we’re very pleased to now be able to offer a solution,” says Elixinol group CEO Oliver Horn.
“The relationship with PharmaCann gives us the ability to see Elixinol branded products in our home market in a way which fits within current regulations.”
As a wholesaler PharmaCann has a wide distribution network into major pharmacy chains including Chemist Warehouse, TerryWhite Chemmart, Priceline Pharmacy, and more.
The company also services more than 1,600 medical practitioners, more than 2,000 pharmacies in Australia and New Zealand and has access to a growing network of more than 130 prescribing doctors.
“At PharmaCann, our ethos is to ensure that all members of our communities have a streamlined access to the most affordable cannabinoid medicines in the market,” says PharmaCann managing director Victor Caprio.
“By working with Elixinol Global to distribute their products in the region, the continuation of our program on delivering affordable, high quality medicines can be met.” [Read more @ Business News Australia]